11843282

Source:http://linkedlifedata.com/resource/pubmed/id/11843282

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023487, umls-concept:C0024305, umls-concept:C0030705, umls-concept:C0066901, umls-concept:C0175668, umls-concept:C0332293, umls-concept:C0733688
pubmed:issue	1
pubmed:dateCreated	2002-2-14
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9111627
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Idarubicin, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone, http://linkedlifedata.com/resource/pubmed/chemical/Tretinoin, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/promyelocytic leukemia-retinoic..., http://linkedlifedata.com/resource/pubmed/chemical/sobuzoxane
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0925-5710
pubmed:author	pubmed-author:KakishitaEizoE, pubmed-author:OkadaMasayaM, pubmed-author:OkamotoTakahiroT, pubmed-author:PillingerJJ, pubmed-author:TakatsukaHiroyukiH, pubmed-author:WakaeTakeshiT
pubmed:issnType	Print
pubmed:volume	75
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	107-8
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11843282-Aged, pubmed-meshheading:11843282-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11843282-Cyclophosphamide, pubmed-meshheading:11843282-Cytarabine, pubmed-meshheading:11843282-Doxorubicin, pubmed-meshheading:11843282-Etoposide, pubmed-meshheading:11843282-Female, pubmed-meshheading:11843282-Humans, pubmed-meshheading:11843282-Idarubicin, pubmed-meshheading:11843282-Leukemia, Promyelocytic, Acute, pubmed-meshheading:11843282-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:11843282-Lymphoma, Non-Hodgkin, pubmed-meshheading:11843282-Neoplasm Proteins, pubmed-meshheading:11843282-Neoplasms, Second Primary, pubmed-meshheading:11843282-Oncogene Proteins, Fusion, pubmed-meshheading:11843282-Piperazines, pubmed-meshheading:11843282-Prednisolone, pubmed-meshheading:11843282-Remission Induction, pubmed-meshheading:11843282-Tretinoin, pubmed-meshheading:11843282-Tumor Markers, Biological, pubmed-meshheading:11843282-Vincristine
pubmed:year	2002
pubmed:articleTitle	Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
pubmed:publicationType	Letter, Case Reports